Clinical trial
A Open Multi-center Clinical Study on Cefotaxime Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01426191 is registered in ClinicalTrials.gov with Xiangbei Welman Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Open Multi-center Clinical Study on Cefotaxime Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary Tract Infection
- Lead sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- December 31, 2016
- Enrollment
- 2,032 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.